ArticleClinical case reports2026
Stroke as an Initial Presentation of Hepatocellular Carcinoma: A Case Report.
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Stroke as an Initial Presentation of Hepatocellular Carcinoma: A Case Report.Clinical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malignancy and ischemic stroke are major causes of global morbidity and mortality. Thromboembolic strokes secondary to malignancy are uncommon but represent a critical consideration in cryptogenic stroke. We report the case of a 46-year-old female with no significant past medical history who presented with acute rightward gaze deviation. Brain MRI confirmed acute multifocal ischemic infarcts. An extensive workup, including CT angiography and echocardiography, ruled out common stroke mechanisms, leading to a diagnosis of embolic stroke of undetermined source (ESUS) per 2021 AHA guidelines. This prompted a hypercoagulability workup, which revealed a markedly elevated D-dimer. Subsequent investigation showed elevated liver enzymes, and abdominal imaging identified a hepatic mass with contrast-enhanced CT features highly suggestive of hepatocellular carcinoma (HCC). The patient was transferred to oncology services for HCC management. At discharge, her neurological symptoms had partially improved, but she was lost to long-term follow-up, and thus her final oncological outcome is unknown.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.